Atrium Therapeutics, Inc. logo RNA - Atrium Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 8
HOLD 8
SELL 0
STRONG
SELL 0
| PRICE TARGET: $25.00 DETAILS
HIGH: $25.00
LOW: $25.00
MEDIAN: $25.00
CONSENSUS: $25.00
UPSIDE: 225.95%

Institutional Holders (13F)

GURU SHARES VALUE WEIGHT % SHARES CHG ACTION
Cooperman 0 $0 -- -- SOLD
Soros 0 $0 -- -- SOLD
Wood 0 $0 -- -22,708 SOLD

Insider Trading

BUYS (12M) 0
SELLS (12M) 0
DATE INSIDER TITLE TYPE SHARES PRICE VALUE
2026-09-18 Gallagher Kathleen P. director, officer: See Remarks F-InKind 11,632 $8.95 $104K
2026-09-18 Hoyos Rocio Martin officer: Chief Strategy Officer F-InKind 8,320 $8.95 $74K
2026-09-18 Boyce Sarah director F-InKind 126,418 $8.95 $1.1M
2026-09-18 Winslow Brendan R. officer: Chief Financial Officer F-InKind 6,742 $8.95 $60K
2026-09-18 Younis Husam officer: Chief Scientific Officer F-InKind 11,216 $8.95 $100K
2026-09-18 Hughes Steven George officer: Chief Medical Officer F-InKind 21,459 $8.95 $192K
2026-09-18 Flanagan W. Michael director F-InKind 22,812 $8.95 $204K
2026-09-18 Kenney Stephanie officer: See Remarks F-InKind 2,375 $8.95 $21K

Congressional Trading

No congressional trading data for RNA.